Metabolite ratios as potential biomarkers for type 2 diabetes: a DIRECT study

Sophie Molnos, Simone Wahl, Mark Haid, E. Marelise W. Eekhoff, René Pool, Anna Floegel, Joris Deelen, Daniela Much, Cornelia Prehn, Michaela Breier, Harmen H. Draisma, Nienke van Leeuwen, Annemarie M.C. Simonis-Bik, Anna Elisabet Jonsson, Gonneke Willemsen, Wolfgang Bernigau, Rui Wang-Sattler, Karsten Suhre, Annette Peters, Barbara ThorandChristian Herder, Wolfgang Rathmann, Michael Roden, Christian Gieger, Mark H.H. Kramer, Diana van Heemst, Helle Krogh Pedersen, Valborg Gudmundsdottir, Matthias B. Schulze, Tobias Pischon, Eco J.C. de Geus, Heiner Boeing, Dorret I. Boomsma, Anette G. Ziegler, P. Eline Slagboom, Sandra Hummel, Marian Beekman, Harald Grallert, Søren Brunak, Mark I. McCarthy, Ramneek Gupta, Ewan R. Pearson, Jerzy Adamski, Leen M. 'T Hart*

*Corresponding author for this work

    Research output: Contribution to journalJournal articleResearchpeer-review

    106 Downloads (Pure)


    Aims/hypothesis: Circulating metabolites have been shown to reflect metabolic changes during the development of type 2 diabetes. In this study we examined the association of metabolite levels and pairwise metabolite ratios with insulin responses after glucose, glucagon-like peptide-1 (GLP-1) and arginine stimulation. We then investigated if the identified metabolite ratios were associated with measures of OGTT-derived beta cell function and with prevalent and incident type 2 diabetes. Methods: We measured the levels of 188 metabolites in plasma samples from 130 healthy members of twin families (from the Netherlands Twin Register) at five time points during a modified 3 h hyperglycaemic clamp with glucose, GLP-1 and arginine stimulation. We validated our results in cohorts with OGTT data (n = 340) and epidemiological case–control studies of prevalent (n = 4925) and incident (n = 4277) diabetes. The data were analysed using regression models with adjustment for potential confounders. Results: There were dynamic changes in metabolite levels in response to the different secretagogues. Furthermore, several fasting pairwise metabolite ratios were associated with one or multiple clamp-derived measures of insulin secretion (all p <9.2 × 10−7). These associations were significantly stronger compared with the individual metabolite components. One of the ratios, valine to phosphatidylcholine acyl-alkyl C32:2 (PC ae C32:2), in addition showed a directionally consistent positive association with OGTT-derived measures of insulin secretion and resistance (p ≤ 5.4 × 10−3) and prevalent type 2 diabetes (ORVal_PC ae C32:2 2.64 [β 0.97 ± 0.09], p = 1.0 × 10−27). Furthermore, Val_PC ae C32:2 predicted incident diabetes independent of established risk factors in two epidemiological cohort studies (HRVal_PC ae C32:2 1.57 [β 0.45 ± 0.06]; p = 1.3 × 10−15), leading to modest improvements in the receiver operating characteristics when added to a model containing a set of established risk factors in both cohorts (increases from 0.780 to 0.801 and from 0.862 to 0.865 respectively, when added to the model containing traditional risk factors + glucose). Conclusions/interpretation: In this study we have shown that the Val_PC ae C32:2 metabolite ratio is associated with an increased risk of type 2 diabetes and measures of insulin secretion and resistance. The observed effects were stronger than that of the individual metabolites and independent of known risk factors.
    Original languageEnglish
    Pages (from-to)117-129
    Publication statusPublished - 2018


    • Epidemiology
    • Insulin secretion
    • Metabolomics
    • Prediction of diabetes
    • Type 2 diabetes

    Fingerprint Dive into the research topics of 'Metabolite ratios as potential biomarkers for type 2 diabetes: a DIRECT study'. Together they form a unique fingerprint.

    Cite this